Executive Summary / TL;DR
Headline Callout: BEAT ON EPS & REVENUE | FY26 GUIDANCE RAISED | STANCE: CONSTRUCTIVE
UnitedHealth Group (UNH) reported strong 3Q26 financial results, outperforming market expectations on both top-line revenue and non-GAAP EPS, driven by significant Medical Care Ratio (MCR) compression and operating margin expansion across both UnitedHealthcare and Optum.
Headline Financial Summary
| Line Item | 3Q26 Actual | 3Q25 Actual | YoY Delta | 3Q26 Consensus | Beat / Miss | Notes |
|---|---|---|---|---|---|---|
| Consolidated Revenue | $112.7B | $113.2B | -0.4% | $111.3B | Beat (+$1.4B) | Revenue impacted by strategic portfolio right-sizing |
| Operating Earnings | $6.6B | $4.3B | +53.5% | -- | N/A | Driven by operational discipline and cost management |
| Medical Care Ratio (MCR) | 88.4% | 89.9% | -150 bps | -- | N/A | Benefit from $610M favorable reserve development |
| Operating Cost Ratio | 12.8% | 13.5% | -70 bps | -- | N/A | Efficiency investments and cost control |
| Diluted EPS (GAAP) | $4.56 | $2.59 | +76.1% | N/A | N/A | -- |
| Adjusted EPS (Non-GAAP) | $4.69 | $2.92 | +60.6% | $4.12 | Beat (+$0.57) | Pre-release consensus beat by 13.8% |
| Operating Cash Flow | $5.1B | $5.9B | -13.6% | -- | N/A | 1.2x Net Income vs 2.3x in 3Q25 |
Key Takeaways
- Earnings Beat & Guidance Lift: Non-GAAP EPS of $4.69 beat consensus ($4.12) by $0.57. Full-year 2026 Adjusted EPS guidance was raised to at least $20.50 (from $19.50–$20.00 in 2Q26), and GAAP EPS guidance was raised to at least $19.50 (from $18.45–$18.95).
- Underwriting & MCR Compression: MCR improved 150 bps YoY to 88.4%, aided by $610M in net favorable prior-period medical reserve development (vs. $80M in 3Q25) alongside tighter medical cost management and disciplined pricing.
- Optum Health Turnaround Underway: Optum Health operating margin recovered to 3.2% ($735M operating earnings) from 0.2% ($41M) in 3Q25, despite a 10% YoY revenue contraction caused by exiting non-sustainable value-based care (VBC) markets.
- Membership Contraction vs. Margin Expansion: Total UnitedHealthcare members fell to 48.3M (down 1.8M YoY), reflecting strategic exits in Medicare Advantage (-935k YTD) and Medicaid eligibility redeterminations (-85k in 3Q26). UNH is prioritizing margin quality over member volume.
- Cash Flow Conversion Moderation: Operating cash flow dropped to $5.1B (1.2x Net Income), down sharply from $11.1B (1.9x Net Income) in 2Q26 and $5.9B (2.3x Net Income) in 3Q25.
Stance & Rationale: Constructive. Management is executing effectively on margin recovery and portfolio repricing. While top-line growth is flat-to-down due to strategic member exits, operating profitability and guidance trajectory confirm that the multi-quarter margin squeeze has troughed.
Top Watch Items: MCR trends excluding favorable reserve releases, operating cash flow conversion pace, Medicare Advantage membership stabilizing post-2026 contract exits, and Optum Health margin durability.